You are here

Clinical Trials: Cardiovascular Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, May 2, 2017 - 19:00
Condition:   Pulmonary Arterial Hypertension (PAH)
Interventions:   Biological: Allogeneic Human Cardiosphere-Derived Stem Cells;   Biological: Placebo
Sponsors:   Cedars-Sinai Medical Center;   California Institute for Regenerative Medicine
Not yet recruiting - verified May 2017
Posted: Friday, April 14, 2017 - 19:00
Condition:   Dilated Cardiomyopathy
Intervention:   Biological: CDC infusion
Sponsors:   Okayama University;   Translational Research Informatics Center, Kobe, Hyogo, Japan
Recruiting - verified April 2017
Posted: Monday, March 13, 2017 - 19:00
Condition:   Resistant Hypertension
Intervention:   Other: Exercise Group
Sponsors:   Aveiro University;   University Institute of Maia - ISMAI;   Cardiology Department, Hospital Infante D. Pedro, Centro Hospitalar do Baixo Vouga;   Hypertension and Cardiovascular Unit, Hospital Pedro Hispano, ULS Matosinhos;   Cintesis & Departamento de Medicina da Faculdade de Medicina do Porto
Recruiting - verified March 2017
Posted: Wednesday, March 8, 2017 - 20:00
Conditions:   Hypoplastic Left Heart Syndrome;   Atrioventricular Canal
Intervention:   Biological: MPC; rexlemestrocel-L
Sponsor:   Boston Children’s Hospital
Not yet recruiting - verified March 2017
Posted: Wednesday, March 1, 2017 - 20:00
Condition:   Diabetes Mellitus Foot Ulcer
Interventions:   Procedure: Fat grafting;   Procedure: Fat grafting + platelet rich plasma
Sponsor:   University College, London
Not yet recruiting - verified March 2017
Posted: Wednesday, March 1, 2017 - 20:00
Condition:   Hypoxic-Ischemic Encephalopathy
Intervention:   Procedure: Umbilical Cord Milking
Sponsor:   Jubilee Mission Medical College and Research Institute
Not yet recruiting - verified April 2017
Posted: Sunday, February 12, 2017 - 20:00
Condition:   Quality of Life
Interventions:   Drug: Caduet 10Mg-20Mg Tablet;   Drug: NorvasC® 10 mg Tablets
Sponsor:   Kosin University Gospel Hospital
Not yet recruiting - verified February 2017
Posted: Tuesday, February 7, 2017 - 20:00
Conditions:   Myocardial Infarction;   Stem Cell Transplantation;   Angioplasty, Transluminal, Percutaneous Coronary
Interventions:   Drug: Atorvastatin;   Drug: Intensive Atorvastatin;   Drug: Low dose BMMSC;   Drug: Middle dose BMMSC;   Drug: High dose BMMSC;   Drug: Transplantation
Sponsors:   Yuejin Yang;   Peking Union Medical College Hospital;   The First Hospital of Hebei Medical University;   Zunyi Medical College
Not yet recruiting - verified February 2017
Posted: Friday, January 27, 2017 - 20:00
Conditions:   Peripheral Arterial Disease;   Cardiovascular Diseases;   Vascular Diseases
Interventions:   Drug: Allogeneic Mesenchymal Stromal Cell;   Other: Placebo
Sponsors:   Martin Teraa, MD, PhD;   ZonMw: The Netherlands Organisation for Health Research and Development
Not yet recruiting - verified February 2017
Posted: Monday, January 23, 2017 - 20:00
Condition:   Critical Limb Ischemia Due to Buerger's Disease
Intervention:   Biological: Stempeucel(R)
Sponsor:   Stempeutics Research Pvt Ltd
Not yet recruiting - verified February 2017

Pages